Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Stem Cells Reverse MS in Breakthrough Clinical Trial

Posted by taylor@stemsave.com on Dec 1, 2017 12:30:00 PM

,mnl.png

A team of researchers at the Hadassah Medical Center in Israel has developed a unique method of applying a patient’s own stem cells to restore mobility following progressive multiple sclerosis (MS). MS is an autoimmune disorder in which the body attacks its own neurons and affects millions of people worldwide. Severely progressive MS leads to complete loss of limb function, memory problems, seizures, and even systemic organ failure. This groundbreaking, double-blind, Phase II clinical trial successfully administered autologous (the patient’s own) mesenchymal stem cells, which were cultured and expanded to clinically significant numbers, and then applied directly into the spinal fluid. The treatment simultaneously addressed the two problems of MS - inflammatory immune response and the destruction of the outer coating of neurons that allows for quick signal transduction thereby engendering a significant increase in efficacy.

The results were impressive, with some patients reporting improvement in muscle function in as little as 24 hours. Within a few days, patients reported being able to exercise and move as they did before the onset of the disease.  “It is a matter of definitely less than 10 years, maybe less than five, that we can have this treatment available, and not only for this indication, because if it works in one type of regeneration of the brain in MS, it may work equally or even better in those such as Alzheimer’s, Parkinson’s, stroke, and spinal trauma,” says Dr. Dimitrios Karussis, head of Hadassah’s Multiple Sclerosis Center.  

 Advances in stem cell based regenerative treatments are creating more effective treatment options for patients suffering from a wide variety of disease, trauma and injury. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.

 

The Future of Regenerative Medicine is Now™

To view the full article, click here.

 

Topics: multiple sclerosis, MS, patient's own mesenchymal stem cells, mesenchymal stem cells, autologous stem cells, multiple sclerosis treatment

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Recent Posts

Posts by Topic

see all